October 5 2024

Join us for an extraordinary gathering featuring some of the industry's most influential figures at our upcoming conference on October 5th. We are delighted to host distinguished speakers such as Sabine Hadida, Vertex site head and this year’s Breakthrough Awardee; Sarah Boyce, Avidity Bioscience CEO; Ken Song, Candid Therapeutics CEO and former RayzeBio CEO; David Bredt, Rapport founder and CSO; Tim Lucker, Lilly Ventures managing partner and head of West Coast; and Diane Simeone, the new director of UCSD Moores Cancer Center.
 
These visionaries are set to share their insights and expertise in sessions covering a range of pivotal topics. Highlights include engaging Fireside Chats on Taking a Research Organization towards Commercialization, celebrating Breakthrough Prize Winner achievements in Serial Innovation in Drug Development, and exploring the journey From Academia to Industry in Neuroscience IPOs. Discover the transformative impact of Moores Cancer Center’s New Director, a world-renowned Pancreatic Surgeon, and delve into cutting-edge innovations like Next-Gen Chemoproteomics Platforms that are revolutionizing Drug Discovery. Don’t miss discussions on Premier Radiopharma in M&A and more.
 
For complete details and to view our comprehensive agenda, we invite you to visit our program page. We look forward to welcoming you on October 5th for what promises to be an enlightening and inspiring event.